RAPT

RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to transforming the treatment landscape for oncology and inflammatory diseases through its innovative oral small molecule therapies. The company's robust pipeline is driven by its proprietary drug discovery platform, which targets critical pathways in immune regulation. With a focus on addressing significant unmet medical needs, RAPT is positioned to advance multiple candidates through clinical development, potentially offering novel therapeutic options for patients and contributing to the evolution of personalized medicine in immunology.